SEC Form 4 · accession 0001209191-16-097060
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Allen Myszkowski
Officer — Chief Financial Officer
Period of report
Feb 6, 2016
Accepted (ET)
Feb 9, 2016 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 6, 2016 | F | 13,048 | $3.46 | D | 121,952 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction reflects the payment of the tax liability by withholding securities incident to the vesting of restricted stock units.